F. Ponthan

J. Haeggström, Ninib Baryawno, P. Kogner, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression

O. Heidenreich, H. Blair, J. Vormoor, 2013, Leukemia.

Gene Silencing by RNAi in Mammalian Cells

O. Heidenreich, N. M. Soria, F. Ponthan, 2015, Current protocols in molecular biology.

The synthetic retinoid RO 13‐6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo

J. Castro, L. Klevenvall, P. Kogner, 2003, International journal of cancer.

Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat

P. Bjellerup, L. Klevenvall, P. Kogner, 2001, British Journal of Cancer.

NSAIDs in neuroblastoma therapy.

P. Kogner, J. Johnsen, B. Sveinbjörnsson, 2005, Cancer letters.

RETINOIDS IN EXPERIMENTAL NEUROBLASTOMA THERAPY

F. Ponthan, 2003 .

The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.

P. Borgström, C. Redfern, P. Kogner, 2001, Medical and pediatric oncology.

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia

M. Konopleva, R. Klose, O. Heidenreich, 2017, Cell reports.

The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo

B. Sveinbjørnsson, M. Wikman, Ø. Rekdal, 2006, International journal of cancer.

Targeting the MAPK7/MMP9 axis for metastasis in primary bone cancer

D. Rassl, M. Kassiou, W. Fraser, 2020, Oncogene.

COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib

J. Lunec, E. Bell, C. Redfern, 2014, Clinical & Experimental Metastasis.

Cell Survival Signalling through PPARδ and Arachidonic Acid Metabolites in Neuroblastoma

F. Westermann, E. Bell, H. Thomas, 2013, PloS one.

Human polyomavirus BK (BKV) and neuroblastoma: mechanisms of oncogenic action and possible strategy for novel treatment.

T. Traavik, T. Flaegstad, P. Kogner, 2000, Medical and pediatric oncology.

Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.

T. Ekström, S. Gray, P. Kogner, 2003, International journal of oncology.

Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression

M. Seto, O. Heidenreich, H. Blair, 2013, Leukemia.

Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.

B. Sveinbjørnsson, T. Flaegstad, P. Kogner, 2004, International journal of oncology.

Celecoxib Prevents Neuroblastoma Tumor Development and Potentiates the Effect of Chemotherapeutic Drugs In vitro and In vivo

S. Eksborg, C. Redfern, P. Kogner, 2007, Clinical Cancer Research.

Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia

S. Cockell, O. Heidenreich, H. Blair, 2017, Leukemia.

Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.

J. Castro, P. Kogner, M. Lindskog, 2003, Oncology reports.

Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations.

C. Spenger, B. Nordell, A. Gräslund, 2005, Cancer letters.

Celecoxib Prevents NeuroblastomaTumor Development and Potentiates the Effect of Chemotherapeutic Drugs In vitro and In vivo

S. Eksborg, C. Redfern, P. Kogner, 2007 .

Omega‐3 fatty acid supplementation delays the progression of neuroblastoma in vivo

M. Hamberg, P. Kogner, J. Johnsen, 2011, International journal of cancer.

A Drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETO

O. Heidenreich, V. Gobert, M. Haenlin, 2009, Proceedings of the National Academy of Sciences.